Post-market Clinical Follow-up Study Plan for Disposable Endoscopic Linear Cutter Stapler
Launched by SUZHOU KERUI MEDICAL TECHNOLOGY CO., LTD · Nov 4, 2024
Trial Information
Current as of November 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a medical device called a disposable endoscopic linear cutter stapler, which is used during surgeries to help cut and connect tissues in the body. The study aims to evaluate how safe and effective this stapler is for procedures that involve removing or joining soft tissues, such as during general or thoracic surgeries. Researchers will analyze past clinical data to understand how well this device performs.
Anyone can participate in this trial as long as they are having endoscopic surgery, which is a type of minimally invasive procedure where doctors use a small camera and instruments. However, patients who have certain conditions that might make using the stapler unsafe, or those who are having surgery with other similar devices, will not be eligible. While the study is not yet recruiting participants, it will provide valuable information on how this stapler can be used safely and effectively in surgical procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age unlimited and gender unlimited;
- • The surgery type shall be endoscopic surgery;
- • The departments of surgical procedures: general and thoracic surgical procedures;
- • Investigational devices of all the models of the staplers and its cartridge listed in Section 2.3.
- Exclusion Criteria:
- • Patients undergoing surgery for contraindications to the product, such as severe mucosal edema, non-observation of hemostatic sites for surgery or off-label use, such as liver and spleen;
- • Combined with other similar products (stapler) for resection, transection and anastomosis of the surgical site;
- • Surgery record is incomplete, unable to extract main indicators related information.
About Suzhou Kerui Medical Technology Co., Ltd
Suzhou Kerui Medical Technology Co., Ltd. is a leading innovator in the medical device industry, specializing in the development and commercialization of advanced healthcare solutions. With a strong focus on research and development, the company leverages cutting-edge technology to enhance patient outcomes and improve clinical processes. Committed to quality and regulatory compliance, Suzhou Kerui collaborates with healthcare professionals and institutions to deliver state-of-the-art medical products that address the evolving needs of the global market. Their dedication to excellence positions them as a trusted partner in clinical trials and medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wujin District, Changzhou, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported